Regencell Bioscience

RGCNasdaq Hong Kong Health Care Medicinal Chemicals and Botanical Products

Market cap

$2.608 B

$5.26 -2.95%

Close of 6 Nov 2026

As of 6 Nov 2026, Regencell Bioscience (RGC) has a market capitalization of $2.61B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$3.58M

Loss-making

Shares outstanding

495,884,376

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →

#3Altria GroupMO$129.3B
#4Definium TherapeuticsDFTX$4.09B
#5Regencell BioscienceRGC$2.61B
#6Trulieve CannabisTRLV$2.11B
#7RLX TechnologyRLX$1.98B

What if Regencell Bioscience were worth as much as…

Open the what-if tool →

Gold $28.2T

$56,942.46

Per share 10,826× higher

Bitcoin $1.53T

$3,081.06

Per share 586× higher

Apple $5.02T

$10,114.82

Per share 1,923× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Regencell Bioscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.